CCR2 and neoplasm: The CCR2 ligand CCL2 has been observed to be upregulated in EBV lymphoma lines (39); therefore, higher CCR2 expression indicates an increased capacity for peptide VST to migrate to and infiltrate within the tumor microenvironment (40).